Takeda Pharmaceutical Company, Ltd

Grantee website osaka-shi, Japan

Purpose

to increase total global capacity to meet potential demand for Inactivated Poliovirus Vaccine (IPV) in 2019/2020, and ensure adequate vaccine supply at an affordable cost.

Division

Global Development

Date

MAY 2016

Region served

GLOBAL

Committed amount

$22,942,125

Grant topic

Polio

Duration (months)

43

Grantee location

osaka-shi, Japan

Related work

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.